Join the Oncology Voice Network. Join for Free
Turning Training into Real Impact in Oncology

Turning Training into Real Impact in Oncology


Share This Article


Summary

Why do so many teams invest in oncology training, but see little change when it truly matters?

In this episode of Oncology Voice Network, host Dr. Kirk Shepard sits down with Gregg Terry, President and CEO of Educational Resource Systems, for a candid exploration of why life sciences training often falls short and what actually drives real behavior change in the field. Drawing on decades of experience launching over 150 products, Gregg Terry shares eye-opening stories and lessons learned from the front lines of pharmaceutical education. Discover why teams “check the box” on learning but still struggle to execute, the difference between information and transformation, and how high-performing oncology teams leverage adaptability, communication, and accountability to create measurable impact, especially during critical launches. This episode unpacks the pitfalls of one-size-fits-all education and the simple habit shifts organizations need to drive meaningful change at scale.

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
OVN Avatar Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Article
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
OVN Avatar Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Explore OVN